Welcome, dear scientific sleuths, to a tale that will both amuse and enlighten as we unravel the...
Welcome, dear scientific sleuths, to a tale that will both amuse and enlighten as we unravel the...
A case study of a pharmaceutical client who supplemented in-house capacity with Culture's...
The recent increase in consumer demand for sustainably made products has led to a surge in the...
Joyn Bio is engineering microbes for sustainable agriculture. Joyn’s Head of Bioprocessing Kelly...
Culture's client Nektar Therapeutics is exploring new PEG-based modifications to therapeutic...
revised December 8, 2022
Is COVID-19 affecting your lab operations? Run bioprocess experiments from...
Modern Meadow, one of Culture Biosciences’ first customers, is biomanufacturing the next generation...
We spoke with Stefan De Kok, PhD, Director of Fermentation at Zymergen, about his experience...
Ranjan Patnaik, PhD, the Chief Technology Officer at The EVERY Company, sat down with us to discuss...
We interviewed Darcy Prather, the co-founder and President of Kalion Inc. Kalion is working to...
What could you achieve with more bioreactor capacity?
You’re no longer limited by the bioreactor capacity in your lab.
© Culture Biosciences. All rights reserved.